Amphastar Pharmaceuticals Inc (AMPH)
41.00
+0.09
(+0.22%)
USD |
NASDAQ |
Apr 24, 16:00
40.98
-0.02
(-0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Total Assets (Quarterly): 1.513B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.513B |
| September 30, 2023 | 1.545B |
| June 30, 2023 | 1.378B |
| March 31, 2023 | 773.66M |
| December 31, 2022 | 741.99M |
| September 30, 2022 | 726.70M |
| June 30, 2022 | 723.72M |
| March 31, 2022 | 716.24M |
| December 31, 2021 | 671.53M |
| September 30, 2021 | 651.68M |
| June 30, 2021 | 665.74M |
| March 31, 2021 | 645.74M |
| December 31, 2020 | 631.24M |
| September 30, 2020 | 613.72M |
| June 30, 2020 | 600.06M |
| March 31, 2020 | 572.83M |
| December 31, 2019 | 586.97M |
| September 30, 2019 | 585.64M |
| June 30, 2019 | 601.30M |
| March 31, 2019 | 544.72M |
| December 31, 2018 | 513.56M |
| Date | Value |
|---|---|
| September 30, 2018 | 480.64M |
| June 30, 2018 | 451.65M |
| March 31, 2018 | 449.78M |
| December 31, 2017 | 451.07M |
| September 30, 2017 | 437.77M |
| June 30, 2017 | 444.00M |
| March 31, 2017 | 435.61M |
| December 31, 2016 | 427.74M |
| September 30, 2016 | 428.84M |
| June 30, 2016 | 408.59M |
| March 31, 2016 | 395.01M |
| December 31, 2015 | 390.14M |
| September 30, 2015 | 395.03M |
| June 30, 2015 | 398.93M |
| March 31, 2015 | 396.50M |
| December 31, 2014 | 389.37M |
| September 30, 2014 | 401.13M |
| June 30, 2014 | 397.27M |
| March 31, 2014 | 345.11M |
| December 31, 2013 | 338.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
572.83M
Minimum
Mar 2020
1.545B
Maximum
Sep 2023
786.56M
Average
665.74M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 64.01B |
| Dentsply Sirona Inc | 7.37B |
| Pacira BioSciences Inc | 1.574B |
| Organon & Co | 12.06B |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 873.49M |
| Shareholders Equity (Quarterly) | 639.42M |
| Debt to Equity Ratio | 0.9227 |
| Current Ratio | 2.172 |
| Net Debt Paydown Yield | -3.46% |